Flamma Group is a CDMO headquartered near Milan, Italy, that specializes in GMP manufacturing of small molecule APIs, novel chemical entities (NCEs), regulatory starting materials (RSMs), and advanced intermediates. Founded in 1950, Flamma provides early-stage and preclinical through large-scale commercial manufacturing from facilities located in Europe, the United States, and China. In addition to their GMP manufacturing of generic APIs and intermediates, Flamma provides custom development and manufacturing services that include process development, scale-up, and commercialization of novel products. Their capabilities also include HPAPI support, continuous flow manufacturing, cryogenic manufacturing, and crystallization research.